Answers are grounded in this paper and cite their sources.
Study reveals significant gene expression patterns associated with chemoresistance in angiosarcoma, indicating potential therapeutic targets.
Background: Angiosarcoma (AS), a clinically aggressive cancer of endothelial origin, is a rare subtype of soft-tissue sarcoma characterised by resistance to chemotherapy and poor prognosis. This study aims to identify transcriptomic biomarkers of chemoresistance in angiosarcoma. Methods: Transcriptomic profiles of 72 Asian AS formalin-fixed paraffin embedded (FFPE) tissue samples were analysed using the NanoString PanCancer IO 360™ Panel and correlated with clinicopathological data. Whole transcriptome data of a subset of samples were available for tumour (n=12) and matched normal tissue (n=6). Differential gene expression of a subset of 35 patients treated with palliative chemotherapy was correlated with treatment response to determine candidate biomarkers of chemoresistance (defined as stable disease or progression). Protein expression of the top candidate biomarker, SPP1, was verified using immunohistochemistry (IHC) on the tissue samples. Correlation of SPP1 protein expression with chemoresistance was examined on two patient-derived AS cell lines. Results: NanoString profiling revealed significant overexpression of genes including SPP1 (log2foldchange -3.49, adj. p=0.0112), CXCL13, CD48 and CLEC5A, accompanied by significant enrichment of myeloid compartment and cytokine and chemokine signalling pathways, as well as neutrophils and macrophages, in chemoresistant tumours. RNA-seq data revealed higher SPP1 expression (p=0.0008) in tumour tissues over adjacent normal compartments. IHC showed a significant moderate positive correlation with SPP1 mRNA expression (r=0.7016; p<0.00110). Higher SPP1 protein expression correlated with lower chemotherapeutic sensitivity in AS cell lines. Further analysis on SPP1-overepressed tumours revealed significant overexpression (adjusted p<0.001) of myeloid compartment pathway genes (SLC11A1, CXCL3, CXCL2, TREM1, IL1β) and cytokine and chemokine signalling pathway genes (CXCL3, IL6, CXCL2, IL1β). Conclusions: Our findings suggest that SPP1 overexpression is a biomarker of chemoresistance and poor prognosis in angiosarcoma and is thus a potential therapeutic target. Future research includes validating our results in a larger independent study as well as elucidating the molecular mechanisms of SPP1-mediated chemoresistance. Citation Format: Glenys Mai Shia Khor, Tiffany Rui En Tan, Elizabeth Chun Yong Lee, Bavani Kannan, Boon Yee Lim, Tun Kiat Ko, Jason Yongsheng Chan. High-throughput Transcriptomics Identifies Chemoresistance-associated Gene Expression Signatures in Human Angiosarcoma [abstract]. In: Proceedings of Frontiers in Cancer Science 2024; 2024 Nov 13-15; Singapore. Philadelphia (PA): AACR; Cancer Res 2025;85(15_Suppl):Abstract nr P33.
No takes yet. Share an insight, caveat, or question.
Khor et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: